Parol + Pedifen

Parol-Pedifen is a product line marketed by Dafra Pharma, consisting of two distinct analgesic and antipyretic medications: Parol (paracetamol) and Pedifen (ibuprofen). Parol is a small molecule analgesic and antipyretic used for the treatment of mild to moderate pain and fever. Pedifen is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting prostaglandin synthesis through the targeting of cyclooxygenase enzymes, providing analgesic, antipyretic, and anti-inflammatory effects. These products are approved and marketed across various Sub-Saharan African countries, including Angola, Benin, and Cameroon, for the management of fever, pain, and inflammatory conditions in both adult and pediatric populations.

Brand names

ParolPedifenParol-Pedifen

Other names

paracetamol + ibuprofenacetaminophen + ibuprofen